BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2527301)

  • 1. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
    Tinel M; Descatoire V; Larrey D; Loeper J; Labbe G; Letteron P; Pessayre D
    J Pharmacol Exp Ther; 1989 Aug; 250(2):746-51. PubMed ID: 2527301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin.
    Fisher D; Labbe G; Berson A; Tinel M; Loeper J; Larrey D; Pessayre D
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat.
    Wrighton SA; Schuetz EG; Watkins PB; Maurel P; Barwick J; Bailey BS; Hartle HT; Young B; Guzelian P
    Mol Pharmacol; 1985 Sep; 28(3):312-21. PubMed ID: 3875783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats.
    Larrey D; Tinel M; Pessayre D
    Biochem Pharmacol; 1983 May; 32(9):1487-93. PubMed ID: 6860368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
    Pessayre D; Tinel M; Larrey D; Cobert B; Funck-Brentano C; Babany G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):685-91. PubMed ID: 6600790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats.
    Ohmori S; Ishii I; Kuriya S; Taniguchi T; Rikihisa T; Hirose S; Kanakubo Y; Kitada M
    Drug Metab Dispos; 1993; 21(2):358-63. PubMed ID: 8097709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of roxithromycin, erythromycin and troleandomycin on their N-demethylation by rat and human cytochrome P450 enzymes.
    Yamazaki H; Hiroki S; Urano T; Inoue K; Shimada T
    Xenobiotica; 1996 Nov; 26(11):1143-53. PubMed ID: 8948090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
    Hostetler KA; Wrighton SA; Molowa DT; Thomas PE; Levin W; Guzelian PS
    Mol Pharmacol; 1989 Mar; 35(3):279-85. PubMed ID: 2784534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450.
    Danan G; Descatoire V; Pessayre D
    J Pharmacol Exp Ther; 1981 Aug; 218(2):509-14. PubMed ID: 7252850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of macrolide antibiotics on drug metabolism in rats and in humans.
    Pessayre D
    Int J Clin Pharmacol Res; 1983; 3(6):449-58. PubMed ID: 6381341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions and hepatitis produced by some macrolide antibiotics.
    Pessayre D; Larrey D; Funck-Brentano C; Benhamou JP
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():181-94. PubMed ID: 3877043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p.
    Wrighton SA; Maurel P; Schuetz EG; Watkins PB; Young B; Guzelian PS
    Biochemistry; 1985 Apr; 24(9):2171-8. PubMed ID: 3888267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-induction by oleandomycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Comparison with troleandomycin.
    Pessayre D; Descatoire V; Tinel M; Larrey D
    J Pharmacol Exp Ther; 1982 Apr; 221(1):215-21. PubMed ID: 6977641
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the pregnenolone-16 alpha-carbonitrile-inducible form of rat liver microsomal cytochrome P-450 and UDP-glucuronosyltransferase.
    Arlotto MP; Sonderfan AJ; Klaassen CD; Parkinson A
    Biochem Pharmacol; 1987 Nov; 36(22):3859-66. PubMed ID: 3120728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clotrimazole induction of cytochrome P-450: dose-differentiated isozyme induction.
    Ritter JK; Franklin MR
    Mol Pharmacol; 1987 Feb; 31(2):135-9. PubMed ID: 3100941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro formation of metabolic-intermediate cytochrome P450 complexes in rabbit liver microsomes by tiamulin and various macrolides.
    Carletti M; Gusson F; Zaghini A; Dacasto M; Marvasi L; Nebbia C
    Vet Res; 2003; 34(4):405-11. PubMed ID: 12911857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some erythromycin derivatives are strong inducers in rats of a cytochrome P-450 very similar to that induced by 16 alpha-pregnenolone carbonitrile.
    Sartori E; Delaforge M; Mansuy D; Beaune P
    Biochem Biophys Res Commun; 1985 May; 128(3):1434-9. PubMed ID: 3873941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer culture.
    Watkins PB; Wrighton SA; Schuetz EG; Maurel P; Guzelian PS
    J Biol Chem; 1986 May; 261(14):6264-71. PubMed ID: 3486184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin.
    Delaforge M; Sartori E; Mansuy D
    Chem Biol Interact; 1988; 68(3-4):179-88. PubMed ID: 3265076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.